CARLSBAD, Calif., Feb. 27,
2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq:
TYRA), a clinical-stage biotechnology company focused on developing
next-generation precision medicines that target large opportunities
in Fibroblast Growth Factor Receptor (FGFR) biology, today
announced that company management will participate in the following
investor conferences:
- TD Cowen's 44th Annual Healthcare Conference,
March 4-6th: Todd Harris,
CEO of TYRA, will present a company overview on Wednesday, March 6, 2024, at 2:10 pm ET. TYRA management will also
participate in one-on-one meetings with investors during the
conference.
- Jefferies Biotech On the Bay Summit, March
11-13th: TYRA management will participate in one-on-one
meetings with investors during the conference.
- Barclays 26th Annual Global Healthcare
Conference, March
12-14th: Todd
Harris, CEO of TYRA, will participate in a fireside
chat on Thursday, March
14th, 2024, at 8:00 am
ET. TYRA management will also participate in
one-on-one meetings with investors during the conference.
A live and archived webcast of the Cowen presentation and
Barclays fireside chat will be available via the For
Investors page on the Investor section of the TYRA
website.
About Tyra Biosciences
Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage
biotechnology company focused on developing next-generation
precision medicines that target large opportunities in FGFR
biology. The Company's in-house precision medicine platform, SNÅP,
enables rapid and precise drug design through iterative molecular
SNÅPshots that help predict genetic alterations most likely to
cause acquired resistance to existing therapies. TYRA's initial
focus is on applying its accelerated small molecule drug discovery
engine to develop therapies in targeted oncology and genetically
defined conditions. TYRA is based in Carlsbad, CA.
For more information about our science, pipeline and people,
please visit www.tyra.bio and engage with us on LinkedIn.
Contact:
Amy Conrad
aconrad@tyra.bio
View original content to download
multimedia:https://www.prnewswire.com/news-releases/tyra-biosciences-to-present-at-upcoming-investor-conferences-302072664.html
SOURCE Tyra Biosciences